Cargando…

Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis

PURPOSE: To assess and compare the relative efficacy and safety of anti-SARS-CoV-2 antibody regimens for COVID-19. METHODS: This systematic review and random-effects network meta-analysis was conducted according to PRISMA-NMA. Literature searches were conducted across MEDLINE, EMBASE, PubMed, Web of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jiawen, Heybati, Kiyan, Ramaraju, Harikrishnaa Ba, Zhou, Fangwen, Rayner, Daniel, Heybati, Shayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016212/ https://www.ncbi.nlm.nih.gov/pubmed/35438413 http://dx.doi.org/10.1007/s15010-022-01825-8

Ejemplares similares

Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2023)

Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2021)

Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
por: Deng, Jiawen, et al.
Publicado: (2023)

Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis
por: Deng, Jiawen, et al.
Publicado: (2022)

Dexmedetomidine versus Propofol Sedation for Prevention of Postoperative Delirium: Clarifications Required [Letter]
por: Deng, Jiawen, et al.
Publicado: (2021)

Outcomes of COVID-19 manuscripts submitted to the Canadian Journal of Anesthesia: a retrospective audit of author gender and person of colour status
por: Heybati, Kiyan, et al.
Publicado: (2023)

Analysis of Relationship between Tumor Necrosis Factor Alpha Gene (G308A Polymorphism) with Preterm Labor
por: Jafarzadeh, Lobat, et al.
Publicado: (2013)

rs12480307 and rs6050307 Polymorphisms of VSX1 Gene in Patient with Keratoconusin Southwest Iran Using PCR-RFLP
por: KARAMI ESHKAFTAKI, Raziyeh, et al.
Publicado: (2018)

The use of acupuncture in patients with Raynaud’s syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Zhou, Fangwen, et al.
Publicado: (2022)

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
por: Ramirez, Giuseppe A., et al.
Publicado: (2023)

Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
por: Bai, Ming, et al.
Publicado: (2022)

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
por: Jizzini, Mazen, et al.
Publicado: (2020)

(411) Safety and Efficacy of Monoclonal Antibodies Against Sars-Cov-2 in a Heart Transplant Population
por: Brink, H., et al.
Publicado: (2023)

Efficacy, Pharmacokinetics, and Toxicity Profiles of a Broad Anti-SARS-CoV-2 Neutralizing Antibody
por: Godínez-Palma, Silvia, et al.
Publicado: (2023)

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
por: Shiravi, Amir Abbas, et al.
Publicado: (2021)

Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials
por: Zhou, Fangwen, et al.
Publicado: (2022)

Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
por: Almagro, Juan C., et al.
Publicado: (2022)

“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Efficacy, Safety and Immunogenicity of Anti-SARS-CoV-2 Vaccines in Patients with Cirrhosis: A Narrative Review
por: Toutoudaki, Konstantina, et al.
Publicado: (2023)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
por: Kreye, Jakob, et al.
Publicado: (2023)

Absence of SARS‐CoV‐2 RNA and anti‐SARS‐CoV‐2 antibodies in stray cats
por: Stranieri, Angelica, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021)

Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
por: Ziganshina, Marina M., et al.
Publicado: (2023)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022)

Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2021)

Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
por: Zhang, Xin-Lin, et al.
Publicado: (2015)

Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies
por: Tani, Chiara, et al.
Publicado: (2021)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Duration of anti-SARS-CoV-2 antibodies much shorter in India
por: Kumar, Nishant, et al.
Publicado: (2021)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
por: Naranbhai, Vivek, et al.
Publicado: (2020)

Establishment of a reference panel for the detection of anti-SARS-CoV antibodies()()
por: Liu, Chunyu, et al.
Publicado: (2007)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

Automated ELISA On-Chip for the Detection of Anti-SARS-CoV-2 Antibodies
por: González-González, Everardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vp58g58iaqi9mlsq318r90robr